Lantheus Holdings, Inc. SEC filings LNTH

Lantheus Holdings, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Aug 5, 2016. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Mar 20, 2026 Dec 31, 2025
10-K Annual report Feb 26, 2026 Dec 31, 2025
ARS Annual report to shareholders Mar 21, 2025 Dec 31, 2024
10-K Annual report Feb 26, 2025 Dec 31, 2024
ARS Annual report to shareholders Mar 15, 2024 Dec 31, 2023
10-K Annual report Feb 22, 2024 Dec 31, 2023
ARS Annual report to shareholders Mar 17, 2023 Dec 31, 2022
10-K Annual report Feb 23, 2023 Dec 31, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
10-K Annual report Feb 25, 2020 Dec 31, 2019
10-K Annual report Feb 20, 2019 Dec 31, 2018
10-K Annual report Feb 26, 2018 Dec 31, 2017
10-K Annual report Feb 23, 2017 Dec 31, 2016

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
LNTH (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bedford, MA
SEC filer status
Large accelerated filer
SEC CIK
1521036
Former names
Lantheus MI Holdings, Inc. (until May 23, 2014)

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.